The regulator says the proposed merger would give the combined company more than 50% of the market for a type of medical ...
The agency is challenging the deal, citing antitrust concerns due to GTCR's existing ownership of Surmodics' rival Biocoat.
The Rolling Meadows-based insurance broker is pushing back its forecast for when the transaction might close as the ...
Zacks Investment Research on MSN1d
SRDX Stock Falls Following Plan for Legal Action Against FTC ChallengeSurmodics, Inc. SRDX recently provided a statement in response to the U.S. Federal Trade Commission (“FTC”) blocking the ...
The FTC said merging Surmodics with Biocoat, where GTCR has a majority stake, would result in one company with over 50% of ...
The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' acquisition by private ...
The Federal Trade Commission sued Thursday to block private equity firm GTCR BC Holdings’ acquisition of Surmodics Inc., ...
The regulator said the buyout “would lead to a highly concentrated market for outsourced hydrophilic coatings and eliminate ...
The Federal Trade Commission on March 6 sued to block GTCR’ s acquisition of Surmodics, alleging that “the deal, which seeks to combine the two largest manufacturers of critical medical device ...
The U.S. Federal Trade Commission (FTC) has sued to block the planned acquisition of medical device company Surmodics (Nasdaq ...
WASHINGTON (Reuters) - The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' ...
Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback